Brought to you by 
PowderMed spins off of Chiron; raises £20mm
May 2004
Executive Summary
PowderMed Ltd., a newly formed company focused on developing therapeutic DNA vaccines, has spun off from Chiron Vaccines and raised £20mm ($35.2mm).
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PowderMed spins off of Chiron; raises £20mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice